Table of Contents

company-logo

Jiangsu Recbio Technology Co., Ltd., a vaccine company, engages in the research, development, and commercialization of subunit vaccines in the People's Republic of China. The company is developing vaccines for the treatment of cervical cancer and genital warts, including REC603, a recombinant human papillomavirus (HPV) 9-valent vaccine that is in phase III clinical trial; REC601 and REC602 recombinant HPV bivalent vaccines, which are in phase I clinical trials; REC604a, a recombinant HPV quadrivalent vaccine that is in pre-clinical stage; and REC604b, a recombinant HPV 9-valent vaccine that is in pre-clinical stage. It is also developing ReCOV, a recombinant COVID-19 vaccine candidate that is in Phase II/III trial; and R520A, a messenger ribonucleic acid COVID-19 vaccine candidate that is in pre-clinical stage; REC610, a recombinant shingles vaccine that is in pre-clinical stage; REC607, a virus vectored adult tuberculosis vaccine that is in pre-clinical stage; REC606, a recombinant adult tuberculosis vaccine that is in pre-clinical stage; REC617, a recombinant influenza quadrivalent vaccine that is in pre-clinical stage; and REC605, a recombinant hand-foot-mouth disease quadrivalent vaccine that is in pre-clinical stage. The company was founded in 2011 and is based in Taizhou, the People's Republic of China.

Jiangsu Recbio Technology Dividend Announcement

• Jiangsu Recbio Technology does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Jiangsu Recbio Technology dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Jiangsu Recbio Technology Dividend History

Jiangsu Recbio Technology Dividend Yield

Jiangsu Recbio Technology current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Jiangsu Recbio Technology stock? Use our calculator to estimate your expected dividend yield:

Jiangsu Recbio Technology Financial Ratios

P/E ratio-6.68
PEG ratio-0.07
P/B ratio4.38
ROE-57.49%
Payout ratio0.00%
Current ratio1.17
Quick ratio0.96
Cash Ratio0.78

Jiangsu Recbio Technology Dividend FAQ

Does Jiangsu Recbio Technology stock pay dividends?
Jiangsu Recbio Technology does not currently pay dividends to its shareholders.
Has Jiangsu Recbio Technology ever paid a dividend?
No, Jiangsu Recbio Technology has no a history of paying dividends to its shareholders. Jiangsu Recbio Technology is not known for its dividend payments.
Why doesn't Jiangsu Recbio Technology pay dividends?
There are several potential reasons why Jiangsu Recbio Technology would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Jiangsu Recbio Technology ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Jiangsu Recbio Technology has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Jiangsu Recbio Technology a dividend aristocrat?
Jiangsu Recbio Technology is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Jiangsu Recbio Technology a dividend king?
Jiangsu Recbio Technology is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Jiangsu Recbio Technology a dividend stock?
No, Jiangsu Recbio Technology is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Jiangsu Recbio Technology stocks?
To buy Jiangsu Recbio Technology you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Jiangsu Recbio Technology stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.